Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus gnrh agonist for prostate cancer treatment: a systematic review and meta-analysis

HIGHLIGHTS

  • who: Li Gu from the United States University of Padua, Italy have published the article: Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis, in the Journal: (JOURNAL)
  • what: Five national databases ranging from 2010 to 2018 in this study showed that only 7.1% of patients were treated with GnRH antagonists as compared to 92.9% of patients treated with GnRH agonists.
  • how: The authors conducted the meta-analysis using a fixed-effects approach (the Mantel-Haenszel technique) . The results . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?